Matthew Jenusaitis Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew Jenusaitis.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew Jenusaitis. Matthew Jenusaitis is a President, Neurovascular Div. in ev3 Inc. ($EVVV) and a Director in Hancock Jaffe Laboratories, Inc. ($HJLI).

Address: 2 GOODYEAR IRVINE 92618 CA

Companies in which Matthew Jenusaitis is an Insider

ev3 Inc.

Trading Symbol: EVVV
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Matthew Jenusaitis: President, Neurovascular Div.
Holdings: 0 shares
Latest Transaction: Apr 04 2006

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Hancock Jaffe Laboratories, Inc.

Trading Symbol: HJLI
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Matthew Jenusaitis: Director
Holdings: 62,500 shares
Latest Transaction: Feb 22 2021

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 62,500
Shares Sold: 0
Share Difference: +62,500
Value Difference: $0

Latest Insider Trading Transactions of Matthew Jenusaitis

Sentiment: All, EVVV, HJLI

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 22 2021HJLIHancock Jaffe Labo ...Jenusaitis MatthewDirectorOption ExerciseA8.205,67346,5195,673
Oct 21 2020HJLIHancock Jaffe Labo ...Jenusaitis MatthewDirectorOption ExerciseA0.40100,00040,000100,000
Oct 21 2020HJLIHancock Jaffe Labo ...Jenusaitis MatthewDirectorOption ExerciseA2.0060,000120,00060,000
Oct 21 2020HJLIHancock Jaffe Labo ...Jenusaitis MatthewDirectorOption ExerciseA0.0078,125078,125
Oct 21 2020HJLIHancock Jaffe Labo ...Jenusaitis MatthewDirectorGrantA0.0062,500062,5000 to 62.5 K
Apr 04 2006EVVVev3 Inc.Jenusaitis MatthewPresident, Neurovas ...Option ExerciseA17.63150,0002,644,500150,000

View all Matthew Jenusaitis insider transactions.